Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16998774rdf:typepubmed:Citationlld:pubmed
pubmed-article:16998774lifeskim:mentionsumls-concept:C0035920lld:lifeskim
pubmed-article:16998774lifeskim:mentionsumls-concept:C0521026lld:lifeskim
pubmed-article:16998774lifeskim:mentionsumls-concept:C0032659lld:lifeskim
pubmed-article:16998774lifeskim:mentionsumls-concept:C0221102lld:lifeskim
pubmed-article:16998774lifeskim:mentionsumls-concept:C0020964lld:lifeskim
pubmed-article:16998774lifeskim:mentionsumls-concept:C0449864lld:lifeskim
pubmed-article:16998774lifeskim:mentionsumls-concept:C2584321lld:lifeskim
pubmed-article:16998774lifeskim:mentionsumls-concept:C0441889lld:lifeskim
pubmed-article:16998774lifeskim:mentionsumls-concept:C0041703lld:lifeskim
pubmed-article:16998774pubmed:dateCreated2006-9-25lld:pubmed
pubmed-article:16998774pubmed:abstractTextAfter the 1989-1991 rubella resurgence, rubella vaccination efforts targeted children and women of childbearing age. Utilizing National Health and Nutrition Examination Survey data collected during 1988-1994 and 1999-2004, we assessed whether US levels of rubella seropositivity are consistent with rubella elimination and whether changes are consistent with immunization efforts. Serum samples with rubella antibody levels > or =10 IU tested by rubella immunoglobulin G enzyme immunoassay were considered to be positive. In 1999-2004, the overall age-adjusted rubella seropositivity level was 91.3% (95% confidence interval [CI], 90.5%-92.1%), a significant increase from 88.1% (95% CI, 86.9%-89.1%) in 1988-1994 (P<.001). Among children, seropositivity was highest in children 6-11 years of age (96.2%), followed by adolescents 12-19 years of age (93.7%). Both groups showed significant increases in immunity levels, in comparison with those in 1988-1994 (P<.001). Among adults, seropositivity among women increased (from 88.9% to 91.5%; P=.015), and there was no change among men (from 87.8% to 88.0%; P=.84). In 1999-2004, population rubella immunity levels were at or above the modeled threshold for elimination of rubella virus transmission. Increases in immunity levels are consistent with vaccination efforts.lld:pubmed
pubmed-article:16998774pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16998774pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16998774pubmed:languageenglld:pubmed
pubmed-article:16998774pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16998774pubmed:citationSubsetIMlld:pubmed
pubmed-article:16998774pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16998774pubmed:statusMEDLINElld:pubmed
pubmed-article:16998774pubmed:monthNovlld:pubmed
pubmed-article:16998774pubmed:issn1537-6591lld:pubmed
pubmed-article:16998774pubmed:authorpubmed-author:ForghaniBaghe...lld:pubmed
pubmed-article:16998774pubmed:authorpubmed-author:ReefSusan ESElld:pubmed
pubmed-article:16998774pubmed:authorpubmed-author:Kruszon-Moran...lld:pubmed
pubmed-article:16998774pubmed:authorpubmed-author:McQuillanGera...lld:pubmed
pubmed-article:16998774pubmed:authorpubmed-author:HydeTerri BTBlld:pubmed
pubmed-article:16998774pubmed:authorpubmed-author:CossenCynthia...lld:pubmed
pubmed-article:16998774pubmed:issnTypeElectroniclld:pubmed
pubmed-article:16998774pubmed:day1lld:pubmed
pubmed-article:16998774pubmed:volume43 Suppl 3lld:pubmed
pubmed-article:16998774pubmed:ownerNLMlld:pubmed
pubmed-article:16998774pubmed:authorsCompleteYlld:pubmed
pubmed-article:16998774pubmed:paginationS146-50lld:pubmed
pubmed-article:16998774pubmed:dateRevised2008-3-20lld:pubmed
pubmed-article:16998774pubmed:meshHeadingpubmed-meshheading:16998774...lld:pubmed
pubmed-article:16998774pubmed:meshHeadingpubmed-meshheading:16998774...lld:pubmed
pubmed-article:16998774pubmed:meshHeadingpubmed-meshheading:16998774...lld:pubmed
pubmed-article:16998774pubmed:meshHeadingpubmed-meshheading:16998774...lld:pubmed
pubmed-article:16998774pubmed:meshHeadingpubmed-meshheading:16998774...lld:pubmed
pubmed-article:16998774pubmed:meshHeadingpubmed-meshheading:16998774...lld:pubmed
pubmed-article:16998774pubmed:meshHeadingpubmed-meshheading:16998774...lld:pubmed
pubmed-article:16998774pubmed:meshHeadingpubmed-meshheading:16998774...lld:pubmed
pubmed-article:16998774pubmed:meshHeadingpubmed-meshheading:16998774...lld:pubmed
pubmed-article:16998774pubmed:meshHeadingpubmed-meshheading:16998774...lld:pubmed
pubmed-article:16998774pubmed:meshHeadingpubmed-meshheading:16998774...lld:pubmed
pubmed-article:16998774pubmed:meshHeadingpubmed-meshheading:16998774...lld:pubmed
pubmed-article:16998774pubmed:year2006lld:pubmed
pubmed-article:16998774pubmed:articleTitleRubella immunity levels in the United States population: has the threshold of viral elimination been reached?lld:pubmed
pubmed-article:16998774pubmed:affiliationNational Center for Immunization and Respiratory Diseases (proposed), Centers for Disease Control and Prevention, Atlanta, GA 30333, USA. thyde@cdc.govlld:pubmed
pubmed-article:16998774pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16998774pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16998774lld:pubmed